Sun Pharma denies material events related to Organon deal speculation
Sun Pharmaceutical Industries responded to stock exchange inquiries regarding media speculation about a potential $12 billion Organon deal, stating no ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
